Gamete Treatment to Correct Fertilization Failure

NARecruitingINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

June 30, 2027

Study Completion Date

November 30, 2027

Conditions
Infertility
Interventions
PROCEDURE

gamete treatment

Patient specimen will be selected through a synthetic, sterile, single-use, culture-tested mesh. The specimen will then be placed in a 37°C environment. After 30 minutes, the selected portion is retrieved from the other side of the mesh. The spermatozoa will be prepared in the standard fashion and utilized for injection or intrauterine insemination after exposure to a membrane permeabilizing agent. Human recombinant PLC-zeta will also be used if the spermatozoa have been confirmed to be PLC-zeta deficient. The injected oocytes will then be exposed to activating agents for the purpose of inducing embryo development. The oocyte activating agent is calcium ionophore and for sperm membrane permeabilization to assist in sperm DNA decondensation is streptolysin O (SLO).

Trial Locations (1)

10021

RECRUITING

Center fo Reproductive Medicine, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER